Paper7435290
Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.
Fodstad H and 1 other. Acta Neurochir (Wien), 1980. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid. Papers, record 7435290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7435290
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclohexanecarboxylic Acids | Major topic |
| Subarachnoid Hemorrhage | Major topic |
| Tranexamic Acid | Major topic |
| Humans |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14016787 | Contribution of radiology to the study of intracranial aneurysms. | Br Med J | 1962 | https://conductscience.org/library/papers/14016787 | PubMed |
| 2 | 5393836 | AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron) a potent haemostatic agent in urinary tract bleeding. | Scand J Urol Nephrol | 1969 | https://conductscience.org/library/papers/5393836 | PubMed |
| 3 | 4684590 | Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage. | Acta Neurol Scand | 1973 | https://conductscience.org/library/papers/4684590 | PubMed |
| 4 | 5072650 | Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study. | Acta Neurol Scand | 1972 | https://conductscience.org/library/papers/5072650 | PubMed |
| 5 | 5790480 | The use of antifibrinolytic substances in ruptured intracranial aneurysms. | Neurochirurgia (Stuttg) | 1969 | https://conductscience.org/library/papers/5790480 | PubMed |
| 6 | 356311 | Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. | Surg Neurol | 1978 | https://conductscience.org/library/papers/356311 | PubMed |
| 7 | 7376944 | Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7376944 | PubMed |
| 8 | 5911370 | Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. Based on 6368 cases in the cooperative study. | J Neurosurg | 1966 | https://conductscience.org/library/papers/5911370 | PubMed |
| 9 | 505491 | Tranexamic acid in subarachnoid hemorrhage. A double-blind study. | Stroke | 1979 | https://conductscience.org/library/papers/505491 | PubMed |
| 10 | 4830928 | Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania. | Med J Aust | 1974 | https://conductscience.org/library/papers/4830928 | PubMed |
| 11 | 346153 | Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? | Br Med J | 1978 | https://conductscience.org/library/papers/346153 | PubMed |
| 12 | 572002 | Computed tomography in aneurysmal subarachnoid hemorrhage. | Neurology | 1979 | https://conductscience.org/library/papers/572002 | PubMed |
| 13 | 517175 | Spontaneous thrombosis of ruptured intracranial aneurysms during treatment with tranexamic acid (AMCA). Report of three cases. | Acta Neurochir (Wien) | 1979 | https://conductscience.org/library/papers/517175 | PubMed |
| 14 | 5808181 | Radioactive albumin microspheres for studies of the pulmonary circulation. | Radiology | 1969 | https://conductscience.org/library/papers/5808181 | PubMed |
| 15 | 365072 | Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. | Ann Neurol | 1977 | https://conductscience.org/library/papers/365072 | PubMed |
| 16 | 354483 | Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. | Ann Neurol | 1978 | https://conductscience.org/library/papers/354483 | PubMed |
| 17 | 5921326 | Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. | J Neurosurg | 1966 | https://conductscience.org/library/papers/5921326 | PubMed |
| 19 | 4718188 | The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage. | Acta Neurol Scand | 1973 | https://conductscience.org/library/papers/4718188 | PubMed |
| 20 | 742821 | The effect of tranexamic acid on the fibrinolytic activity of vein walls. | Ann Chir Gynaecol | 1978 | https://conductscience.org/library/papers/742821 | PubMed |
| 21 | 624294 | Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment. | Eur Neurol | 1978 | https://conductscience.org/library/papers/624294 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7435290
GET https://conductscience.org/api/papers/v1/7435290/authors